MSaarinen
TL3 Regular · Santander, ES
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 31 January 2025 · last posted 4d · groups: journal-club
143 posts, newest first. Showing up to 150.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #50 · Compounds › Repair & healing peptides · 24 Jul 2026 · 30 likes Post #48 answers the question as asked. The question underneath it is different. Nothing in this subcategory is medical advice and several members here are describing…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #88 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 4 likes Adding the boring version of Protein density versus volume, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #60 · Practice › Interactions · 18 Jul 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Seven-day rolling means and why weekly readings mislead Replied, post #50 · Outcomes › Progress reports · 17 Jul 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Revisiting: What pooling buys you and what it destroys Replied, post #92 · Evidence › Meta-analyses · 15 Jul 2026 · 15 likes Worth separating pooling buys as a question about the compound from pooling buys as a question about the documentation. They get answered by different people and only…
-
Documenting a supplier's response to a discrepancy Replied, post #33 · Sourcing › Vendor reports · 8 Jul 2026 · 17 likes Post #29 describes the usual case. This is about the unusual one. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #83 · Evidence › Journal club · 5 Jul 2026 · 0 likes Post #81 describes the usual case. This is about the unusual one. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective…
-
About the Adverse events category Replied, post #5 · Safety › Adverse events · 3 Jul 2026 · 2 likes Interactions with other medicines are a common contributor to events reported here, which is why the full list matters in any report. The step people skip is the one I…
-
Pooling trials with different estimands Replied, post #65 · Evidence › Meta-analyses · 2 Jul 2026 · 10 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Second pass at: Programming during a large energy deficit Replied, post #47 · Nutrition & Training › Resistance training · 26 Jun 2026 · 5 likes Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other. That is my reading. Someone…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #20 · Analytics › Impurities & related substances · 24 Jun 2026 · 28 likes Worth separating two things that post #18 runs together. The honest reading of a purity figure: it is an upper bound on how much of what the method could see was the…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #47 · Compounds › Oral incretins · 18 Jun 2026 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. The gastrointestinal tolerability profile of the oral formulation is broadly similar in…
-
Bioimpedance and hydration: why the number moves Replied, post #61 · Outcomes › Body composition · 16 Jun 2026 · 0 likes Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass.
-
Submitting a sample: the process end to end Replied, post #18 · Sourcing › Independent verification · 15 Jun 2026 · 0 likes Taking post #15 at face value and following it one step further. It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #13 · Sourcing › Vendor reports · 11 Jun 2026 · 0 likes Helpful, and short, which on this subject is harder than long.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #8 · Access › International · 10 Jun 2026 · 4 likes Taking post #5 at face value and following it one step further. Travelling with a prescribed medicine is a documentation question and the requirements are published by…
-
Official shortage notices and what they authorise Replied, post #95 · Access › Shortages · 8 Jun 2026 · 10 likes Everything in post #93 holds. The case it does not cover is the one I have. The bit of official shortage notices that nobody enjoys is that the answer changes depending…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #3 · Practice › Side effects · 7 Jun 2026 · 2 likes Practical note on Taste changes and food aversion: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #93 · Sourcing › Red flags · 6 Jun 2026 · 11 likes Testimonials without a lot, a date, a method or a service are not evidence and are not a red flag either. They are simply not evidence.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #37 · Analytics › Impurities & related substances · 5 Jun 2026 · 10 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #13 · Start Here › Welcome · 3 Jun 2026 · 17 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #36 · Analytics › Home & field testing · 1 Jun 2026 · 1 like Picking up post #33: that is the part I would want checked first. Small correction to my own earlier position on Lateral-flow and colorimetric approaches. I had the…
-
Introducing myself and asking whether my planned first topic belongs anywhere — does… Replied, post #3 · Start Here › Welcome · 28 May 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #17 · Clinical › Special populations · 20 May 2026 · 7 likes The confident answers on bariatric surgery history and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #31 · Analytics › Home & field testing · 19 May 2026 · 6 likes A home refractometer is not measuring what people hope it is measuring in these preparations, and the readings are dominated by everything other than the peptide. If…
-
Blind submission and why it changes minds — the long version Replied, post #80 · Sourcing › Independent verification · 17 May 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Someone should write this up properly, and it…
-
Prescription portability between countries Replied, post #22 · Access › International · 2 May 2026 · 6 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. This is the sort of thing the wiki…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #8 · Analytics › Home & field testing · 1 May 2026 · 20 likes Photographs of test results posted here are worth including with the lighting and the timing stated, because both change the apparent result of a colorimetric method…
-
Bioimpedance and hydration: why the number moves Replied, post #36 · Outcomes › Body composition · 26 Apr 2026 · 9 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Neither method is capable of detecting the month-to-month changes that people report…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #98 · Compounds › Tirzepatide · 26 Apr 2026 · 6 likes Where I part company with post #96, and it is a narrow parting. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
What other technical communities get right that we do not Replied, post #3 · Lounge › Off topic · 23 Apr 2026 · 0 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower. A weak…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #7 · Compounds › Semaglutide · 23 Apr 2026 · 17 likes The failure mode on semaglutide and gastric emptying is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #33 · Analytics › HPLC & UHPLC · 21 Apr 2026 · 3 likes No notes. Posting so the count is not one.
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #12 · Analytics › HPLC & UHPLC · 13 Apr 2026 · 21 likes Post #10 put the caveat in the right place and I want to underline it. This is why a purity figure without the underlying chromatogram is weaker evidence than it…
-
Journal club: is percentage weight change the right endpoint? Replied, post #62 · Evidence › Journal club · 12 Apr 2026 · 0 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
CJC-1295 with and without DAC: what the modification does Replied, post #26 · Compounds › Secretagogues & GH axis · 4 Apr 2026 · 5 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
Moderation log format change Replied, post #41 · Meta › Announcements · 2 Apr 2026 · 15 likes Worth stating the null on moderation log format change before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #27 · Outcomes › Body composition · 22 Mar 2026 · 7 likes Post #26 is the version of this I will quote in future. One addition. Neither method is capable of detecting the month-to-month changes that people report detecting…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #73 · Analytics › Mass spectrometry · 18 Mar 2026 · 0 likes What I would check first on Adducts is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
CJC-1295 with and without DAC: what the modification does Replied, post #13 · Compounds › Secretagogues & GH axis · 14 Mar 2026 · 16 likes Filing a mild objection to the consensus on CJC-1295. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #34 · Practice › Storage & stability · 14 Mar 2026 · 20 likes Agreed on all of that, and I have nothing to add to it.
-
Oral versus injected administration claims for BPC-157 Replied, post #14 · Compounds › Repair & healing peptides · 13 Mar 2026 · 0 likes I had written a reply contradicting post #10 and deleted it. Here is what survived. Second-hand on oral versus injected administration claims, so weight it accordingly…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #28 · Practice › Dosing & titration · 13 Mar 2026 · 2 likes The failure mode on splitting a weekly dose is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Coming back to: Time to steady state after a dose increase Replied, post #11 · Pharmacology › Pharmacokinetics · 9 Mar 2026 · 2 likes Post #10 is right about the mechanism and I think understates the practical bit. Area under the curve is the exposure measure that matters for most effects in this…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #115 · Evidence › Study critique · 6 Mar 2026 · 4 likes Sensible. I would want the same detail before I acted on it either.
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #13 · Outcomes › Progress reports · 4 Mar 2026 · 11 likes Picking up post #12: that is the part I would want checked first. Include what else changed. Training, illness, travel and a different scale all appear in a series as…
-
Micro-titration: a disputed topic, argued properly Replied, post #41 · Practice › Dosing & titration · 2 Mar 2026 · 22 likes I had written a reply contradicting post #39 and deleted it. Here is what survived. Marking my uncertainty on micro-titration explicitly. I am confident about the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #125 · Practice › Dosing & titration · 21 Feb 2026 · 2 likes Taking post #122 at face value and following it one step further. How the published trials escalated: they used specific step sizes and intervals. The STEP programme…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #33 · Evidence › Trials · 10 Feb 2026 · 15 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
Managing an unplanned gap in supply Replied, post #22 · Access › Shortages · 4 Feb 2026 · 3 likes Second-hand on managing an unplanned gap, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #67 · Clinical › Bloodwork · 3 Feb 2026 · 9 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Journal club: LEADER as the historical anchor Replied, post #27 · Evidence › Journal club · 25 Jan 2026 · 22 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. I would be glad to be shown a cleaner way of putting…
-
Filter needles: when they help and what they cost you Replied, post #31 · Devices › Syringes & needles · 20 Jan 2026 · 0 likes A note on scope: what I am saying about filter needles applies to the case in the first post and I would not extend it further without checking.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #56 · Clinical › Bloodwork · 20 Jan 2026 · 23 likes The failure mode on panel is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #42 · Outcomes › Body composition · 19 Jan 2026 · 0 likes Confirming post #41 from a second method, which matters more than confirming it from a second person. Circumference measurements at marked sites, taken consistently,…
-
Liver enzymes drifting down and what that usually means Replied, post #45 · Clinical › Bloodwork · 11 Jan 2026 · 0 likes On post #41 — agreed on the reasoning, with one qualification. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
A partial dose because the pen emptied mid-injection Replied, post #8 · Practice › Administration · 6 Jan 2026 · 11 likes Building on post #5 rather than restating it. Where I have landed on partial dose because the pen, having got it wrong once in public: the direction is clear, the…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #37 · Practice › Storage & stability · 17 Dec 2025 · 12 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
The decimal-point error, and the habit that catches it Replied, post #23 · Practice › Reconstitution · 14 Dec 2025 · 32 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Reading an interaction checker output critically Replied, post #61 · Practice › Interactions · 8 Dec 2025 · 25 likes Adding the measurement that post #60 says would settle it. Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing two…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #36 · Start Here › How to Ask · 26 Nov 2025 · 0 likes Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
Airline travel with a temperature-sensitive injectable Replied, post #16 · Devices › Cold chain · 20 Nov 2025 · 16 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
-
Insomnia at a dose step: reported experiences Replied, post #21 · Wellbeing › Sleep · 31 Oct 2025 · 0 likes Nothing here is medical advice, and suspected sleep-disordered breathing specifically is something to have assessed properly rather than tracked. I would put the burden…
-
Conference abstracts as evidence: the weakest common citation Replied, post #6 · Evidence › Preprints · 30 Oct 2025 · 0 likes Post #4 put the caveat in the right place and I want to underline it. Conference abstracts are weaker than preprints and get quoted with equal confidence. An abstract…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #63 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Pooling trials with different estimands — what changed since Replied, post #40 · Evidence › Meta-analyses · 21 Oct 2025 · 17 likes A meta-analysis of four small trials is not stronger evidence than one adequately powered trial, whatever the summary statistic looks like. It is the sort of thing that…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #40 · Safety › Adverse events · 21 Oct 2025 · 0 likes Picking up post #37: that is the part I would want checked first. Attribution is genuinely hard for a single case and the reporting schemes are designed to work with…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #15 · Start Here › Welcome · 13 Oct 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Titles that describe the question, not the situation Replied, post #119 · Start Here › How to Ask · 11 Oct 2025 · 0 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
Sleep quality changes during weight loss — what changed since Replied, post #20 · Wellbeing › Sleep · 8 Oct 2025 · 0 likes Energy availability affects sleep in both directions, and a large deficit can produce either fragmentation or unusual sleepiness.
-
Availability by country, dated, with primary sources Replied, post #12 · Access › International · 6 Oct 2025 · 6 likes Availability is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
A comparison of home results against a laboratory result on the same vial Replied, post #45 · Analytics › Home & field testing · 5 Oct 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 3 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #65 · Sourcing › Vendor reports · 30 Sep 2025 · 0 likes Confirming post #64 from a second method, which matters more than confirming it from a second person. Multiple services on one lot: agreement across two independent…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #51 · Evidence › Preprints · 29 Sep 2025 · 3 likes Adding the measurement that post #48 says would settle it. A preprint that has been up for two years without appearing in a journal is telling you something, and it is…
-
Payment method and the leverage it gives you, ranked Replied, post #58 · Sourcing › Payments · 22 Sep 2025 · 0 likes Partial shipment with the balance to follow should be agreed in advance rather than discovered on arrival. Where it is agreed, it is unremarkable. Speaking for myself…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #15 · Sourcing › Vendor reports · 13 Sep 2025 · 32 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. A weak preference rather than a position.
-
Pages past their review date, listed Replied, post #30 · Meta › Wiki maintenance · 12 Sep 2025 · 2 likes Adding the measurement that post #29 says would settle it. My experience of pages past contradicts the reply above. I am posting it as a data point rather than as a…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #35 · Analytics › Mass spectrometry · 10 Sep 2025 · 23 likes Tandem mass spectrometry with fragmentation gives sequence information that intact mass cannot. It is the analysis that would actually confirm identity, and it is…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #50 · Practice › Dosing & titration · 9 Sep 2025 · 2 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
Confounding by indication, explained with a concrete example Replied, post #12 · Evidence › Study critique · 1 Sep 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Hypertension improvement and when medication needs revisiting Replied, post #25 · Clinical › Comorbidities · 26 Aug 2025 · 32 likes Hypertension improvement: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #63 · Compounds › Retatrutide · 25 Aug 2025 · 0 likes Taking post #62 at face value and following it one step further. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #16 · Analytics › HPLC & UHPLC · 24 Aug 2025 · 0 likes Taking post #13 at face value and following it one step further. A shallow gradient resolves close-eluting species that a steep one merges. Two honest laboratories…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #80 · Evidence › Journal club · 21 Aug 2025 · 2 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend. A partial answer, offered because a partial answer…
-
When a preprint is the best available evidence and we say so Replied, post #75 · Evidence › Preprints · 19 Aug 2025 · 9 likes Say it is a preprint in the first line rather than the last. Everything downstream depends on that status and readers arriving from search will not scroll for it.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Started this topic · Evidence › Journal club · 7 Aug 2025 · 45 likes Journal club: is percentage weight change the right endpoint? — that is the question, and I have not found it answered plainly anywhere I have looked. A question about…
-
Gauge and length selection for subcutaneous injection Replied, post #14 · Devices › Syringes & needles · 23 Jul 2025 · 23 likes Post #12 describes the usual case. This is about the unusual one. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
Sequence verification for an obscure compound: how it is done Replied, post #96 · Compounds › Other compounds · 18 Jul 2025 · 4 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
A field-by-field walk through a certificate of analysis Replied, post #90 · Analytics › COA interpretation · 17 Jul 2025 · 4 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #126 · Compounds › Tirzepatide · 3 Jul 2025 · 28 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #39 · Sourcing › Regulatory · 2 Jul 2025 · 11 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #13 · Wellbeing › Mental health · 1 Jul 2025 · 3 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #18 · Compounds › Semaglutide · 25 Jun 2025 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Cross-border purchase within the EU: the actual rules Replied, post #2 · Access › International · 17 Jun 2025 · 11 likes On cross-border purchase within: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #105 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 0 likes Post #104 is right about the mechanism and I think understates the practical bit. The version of CagriSema phase 2 paper that circulates here is a simplification of a…
-
Merging two pages that cover the same ground Replied, post #3 · Documentation › Wiki requests · 15 Jun 2025 · 32 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. A request is more likely to succeed with a proposed outline attached.…
-
Half-life, steady state, and accumulation worked through Replied, post #111 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 0 likes On post #109 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #58 · Devices › Pens & autoinjectors · 5 Jun 2025 · 11 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #6 · Start Here › How to Ask · 25 May 2025 · 1 like Post #4 describes the usual case. This is about the unusual one. "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the…
-
Reading a chromatogram someone posted without axes Replied, post #36 · Analytics › HPLC & UHPLC · 23 May 2025 · 27 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #4 · Compounds › Semaglutide · 23 May 2025 · 0 likes The opening post answers the question as asked. The question underneath it is different. Discontinuation rates in the trials are worth reading alongside efficacy and…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #87 · Clinical › Comorbidities · 17 May 2025 · 1 like A definition problem is doing most of the work in this obstructive sleep apnoea discussion. Once the term is pinned down I suspect the disagreement mostly goes away and…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #30 · Evidence › Journal club · 11 May 2025 · 1 like For anyone finding this later: the short answer on SURMOUNT-4 and continuation versus withdrawal is that it depends on one thing, and the rest of the thread is people…
-
Asking about a compound your prescriber has not heard of Replied, post #36 · Clinical › Prescriber conversations · 10 May 2025 · 1 like Everything in post #34 holds. The case it does not cover is the one I have. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #129 · Evidence › Journal club · 23 Apr 2025 · 0 likes If someone has run STEP 1 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #74 · Analytics › Mass spectrometry · 21 Apr 2025 · 0 likes Counterpoint on adducts, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
-
A well-designed study with a badly written abstract Replied, post #30 · Evidence › Study critique · 18 Apr 2025 · 0 likes A note on how well-designed study gets discussed rather than on well-designed study itself: the confident posts get the replies and the careful ones get ignored, and…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #75 · Compounds › Semaglutide · 13 Apr 2025 · 6 likes The 2.4 mg maintenance dose in the weight-management programme and the 1.0 mg diabetes dose are frequently discussed as though they were the same drug at different…
-
Reading order for a first week here, and what to skip until later Replied, post #72 · Start Here › Welcome · 8 Apr 2025 · 0 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Antibiotics and a course of something with delayed emptying Replied, post #11 · Practice › Interactions · 29 Mar 2025 · 2 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. If someone has run antibiotics properly I would rather read that…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #31 · Sourcing › Vendor reports · 28 Mar 2025 · 6 likes Adding the measurement that post #29 says would settle it. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #26 · Practice › Reconstitution · 22 Mar 2025 · 20 likes Post #23 is the version of this I will quote in future. One addition. Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #19 · Practice › Interactions · 18 Mar 2025 · 22 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not gradual.
-
Maintainer handover: how it works Replied, post #69 · Meta › Wiki maintenance · 18 Mar 2025 · 22 likes Confirming post #68 from a second method, which matters more than confirming it from a second person. Evidence synthesis: if you think a page should cover recent…
-
A promotion I argued against, and why I lost Replied, post #137 · Documentation › Doc review · 18 Mar 2025 · 1 like The arithmetic in post #134 is right; the assumption feeding it is the part to check. Adding what did not work for me on promotion, since the failures never get written…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #50 · Pharmacology › Receptor biology · 13 Feb 2025 · 0 likes Post #49 is the version of this I will quote in future. One addition. Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite,…
-
Consistent declarations and why they matter more than clever ones Replied, post #10 · Sourcing › Logistics · 8 Feb 2025 · 15 likes Consistent declarations was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #36 · Evidence › Journal club · 3 Feb 2025 · 16 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
What changed in 2026, by region Replied, post #112 · Access › International · 31 Jan 2025 · 24 likes The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. Correct me on the…
-
Telehealth prescribing models in the US Replied, post #51 · Regional › North America · 28 Jan 2025 · 18 likes Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage varies between public and private insurance. Marking that…
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #23 · Practice › Dosing & titration · 3 Jan 2025 · 32 likes I had written a reply contradicting post #19 and deleted it. Here is what survived. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #74 · Compounds › Semaglutide · 31 Dec 2024 · 6 likes Semaglutide half-life is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #33 · Practice › Interactions · 28 Dec 2024 · 7 likes Posting my Oral contraceptives and delayed emptying numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by…
-
Second pass at: Regression to the mean in progress reports Replied, post #7 · Research Methods › Statistics · 23 Dec 2024 · 9 likes I read the earlier replies on Regression twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather…
-
What changed in 2026, by region Replied, post #36 · Access › International · 23 Dec 2024 · 5 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #23 · Clinical › Special populations · 20 Dec 2024 · 1 like Post #19 and I disagree about the size of the effect, not about the direction. Being outside the studied population does not mean a treatment is unsafe. It means the…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #17 · Safety › Adverse events · 20 Dec 2024 · 0 likes Post #14 is right about the mechanism and I think understates the practical bit. Adding what did not work for me on Persistent vomiting, since the failures never get…
-
Body image changing more slowly than the body Replied, post #60 · Wellbeing › Mental health · 18 Dec 2024 · 23 likes Having read the whole body image thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
-
About the Payments category Replied, post #5 · Sourcing › Payments · 11 Dec 2024 · 32 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #24 · Practice › Side effects · 25 Nov 2024 · 24 likes Adding the measurement that post #22 says would settle it. On injection-site reactions: the maintained page in the documentation commons covers the general case with…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #71 · Compounds › Repair & healing peptides · 16 Nov 2024 · 32 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
EMA product information as a primary source — does this still hold? Replied, post #60 · Regional › European Union · 16 Nov 2024 · 2 likes Adding a null result on EMA product information. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #5 · Practice › Side effects · 15 Nov 2024 · 2 likes The opening post and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined…
-
People with a low starting BMI: where the evidence stops Replied, post #8 · Clinical › Special populations · 16 Oct 2024 · 16 likes Where a population is under-studied, registry data accumulates first and is confounded by indication in ways that are hard to correct.
-
Food noise reducing and the disorientation that can follow Replied, post #21 · Wellbeing › Mental health · 13 Oct 2024 · 3 likes The question underneath food noise is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
A page that has drifted out of date and needs a maintainer Replied, post #15 · Documentation › Wiki requests · 3 Oct 2024 · 9 likes Everything in post #11 holds. The case it does not cover is the one I have. Documents that are mostly a worked example age better than documents that are mostly a…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #64 · Analytics › COA interpretation · 24 Sep 2024 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed field-by-field walk through a certificate, as opposed to read about it? The thread is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #106 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Where I part company with post #104, and it is a narrow parting. Working an example through by hand once makes any of these concepts stick better than reading about…
-
Correlation in a self-tracked dataset: what it can support Replied, post #9 · Research Methods › Statistics · 20 Aug 2024 · 6 likes Where I would push back on the correlation consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
How this community labels and discusses unrefereed work Replied, post #114 · Evidence › Preprints · 26 Jul 2024 · 1 like Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #5 · Compounds › Oral incretins · 19 Jul 2024 · 8 likes Narrowing post #4, because the general version has more than one answer. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
-
Journal club: FLOW and the renal composite, component by component Replied, post #37 · Evidence › Journal club · 12 Jul 2024 · 13 likes I read post #33 twice before replying, because I had assumed the opposite. Reading order that works for these sessions: registry entry, methods, baseline table, primary…